Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease

References

• WinbladBAmouyelPAndrieuSDefeating Alzheimer’s disease and other dementias: a priority for European science and societyLancet Neurol201615545553226987701
   PubMed Web of Science ®Google Scholar
• GrahamWVBonito-OlivaASakmarTPUpdate on Alzheimer’s Disease Therapy and Prevention StrategiesAnnu Rev Med20176841343028099083
   PubMed Web of Science ®Google Scholar
• HampelHPrvulovicDTeipelSThe future of Alzheimer’s disease: the next 10 yearsProg Neurobiol201195471872822137045
   PubMed Web of Science ®Google Scholar
• LochheadJJThorneRGIntranasal delivery of biologics to the central nervous systemAdv Drug Deliv Rev201264761462822119441
   PubMed Web of Science ®Google Scholar
• MistryAStolnikSIllumLNanoparticles for direct nose-to-brain delivery of drugsInt J Pharm2009379114615719555750
   PubMed Web of Science ®Google Scholar
• KulkarniADVanjariYHSanchetiKHBelgamwarVSSuranaSJPardeshiCVNanotechnology-mediated nose to brain drug delivery for Parkinson’s disease: a mini reviewJ Drug Target201523977578825758751
   PubMed Web of Science ®Google Scholar
• DjupeslandPGNasal drug delivery devices: characteristics and performance in a clinical perspective-a reviewDrug Deliv Transl Res201331426223316447
   PubMed Web of Science ®Google Scholar
• JafariehOMdSAliMDesign, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targetingDrug Dev Ind Pharm201541101674168125496439
   PubMed Web of Science ®Google Scholar
• CasettariLIllumLChitosan in nasal delivery systems for therapeutic drugsJ Control Release201419018920024818769
   PubMed Web of Science ®Google Scholar
• GartziandiaOHerranEPedrazJLCarroEIgartuaMHernandezRMChitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administrationColloids Surf B Biointerfaces201513430431326209963
   PubMed Web of Science ®Google Scholar
• PawarDGoyalAKMangalSEvaluation of mucoadhesive PLGA microparticles for nasal immunizationAAPS J201012213013720077052
   PubMed Web of Science ®Google Scholar
• ShengJHanLQinJN-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorptionACS Appl Mater Interfaces2015728154301544126111015
   PubMed Web of Science ®Google Scholar
• HagenaarsNManiaMde JongPRole of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccineJ Control Release20101441172420100528
   PubMed Web of Science ®Google Scholar
• DuPLKotzéAFJungingerHENasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chlorideDrug Deliv201017639940720429846
   PubMed Web of Science ®Google Scholar
• SuzukiYALopezVLönnerdalBMammalian lactoferrin receptors: structure and functionCell Mol Life Sci200562222560257516261254
   PubMed Web of Science ®Google Scholar
• ElfingerMMauckschCRudolphCCharacterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cellsBiomaterials200728233448345517475321
   PubMed Web of Science ®Google Scholar
• QianZMWangQExpression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disordersBrain Res Brain Res Rev19982732572679729418
   PubMedGoogle Scholar
• LiuZJiangMKangTLactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administrationBiomaterials201334153870388123453061
   PubMed Web of Science ®Google Scholar
• GuoCYangZHZhangSIntranasal lactoferrin enhances α-secretase-dependent amyloid precursor protein processing via the ERK1/2-CREB and HIF-1α pathways in an Alzheimer’s disease mouse modelNeuropsychopharmacology201742132504251528079060
   PubMed Web of Science ®Google Scholar
• BiCWangAChuYIntranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatmentInt J Nanomed20161165476559
   PubMed Web of Science ®Google Scholar
• FerreiraARodriguesMFortunaAFalcãoAAlvesGHuperzine A from Huperzia serrata: a review of its sources, chemistry, pharmacology and toxicologyPhytochem Rev20161515185
   Web of Science ®Google Scholar
• ZhangHYNew insights into Huperzine A for the treatment of Alzheimer’s diseaseActa Pharmacol Sin20123391170117522941287
   PubMed Web of Science ®Google Scholar
• YangGWangYTianJLiuJPHuperzine A for Alzheimer’s disease: a systematic review and meta-analysis of randomized clinical trialsPLoS One201389e7491624086396
   PubMed Web of Science ®Google Scholar
• WangZYLiuJGLiHYangHMPharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer’s Disease: A ReviewAm J Chin Med201644081525154127848250
   PubMedGoogle Scholar
• MaTGongKYanYHuperzine A promotes hippocampal neurogenesis in vitro and in vivoBrain Res20131506354323454433
   PubMed Web of Science ®Google Scholar
• HuangXTQianZMHeXReducing iron in the brain: a novel pharmacologic mechanism of Huperzine A in the treatment of Alzheimer’s diseaseNeurobiol Aging20143551045105424332448
   PubMed Web of Science ®Google Scholar
• WangCYZhengWWangTHuperzine A activates Wnt/β−catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse modelNeuropsychopharmacology20113651073108921289607
   PubMed Web of Science ®Google Scholar
• YuePTaoTZhaoYRenJChaiXHuperzine A in rat plasma and CSF following intranasal administrationInt J Pharm20073371–212713217241758
   PubMed Web of Science ®Google Scholar
• TaoTZhaoYYuePDongWXChenQHPreparation of Huperzine A nasal in situ gel and evaluation of its brain targeting following intranasal administrationActa Pharm Sin2006411111041110 Chinese
   Google Scholar
• ZhangLHanLQinJLuWWangJThe use of borneol as an enhancer for targeting aprotinin-conjugated PEG-PLGA nanoparticles to the brainPharm Res201330102560257223615859
   PubMed Web of Science ®Google Scholar
• LiFHuRWangBSelf-microemulsifying drug delivery system for improving the bioavailability of Huperzine A by lymphatic uptakeActa Pharm Sin B20177335336028540173
   PubMed Web of Science ®Google Scholar
• PatelPAPatilSCKalariaDRKaliaYNPatravaleVBComparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine AInt J Pharm20134461–2162323410989
   PubMed Web of Science ®Google Scholar
• ZhaoYYuePTaoTChenQHDrug brain distribution following intranasal administration of Huperzine A in situ gel in ratsActa Pharmacol Sin200728227327817241531
   PubMed Web of Science ®Google Scholar
• HuXJLiuYZhouXFSynthesis and characterization of low-toxicity N-caprinoyl-N-trimethyl chitosan as self-assembled micelles carriers for ostholeInt J Nanomed2013835433558
   PubMedGoogle Scholar
• LiuQZhengXZhangCAntigen-conjugated N-trimethylaminoethylmethacrylate chitosan nanoparticles induce strong immune responses after nasal administrationPharm Res2015321223624970313
   PubMed Web of Science ®Google Scholar
• SharmaDSharmaRKSharmaNNose-To-Brain Delivery of PLGA-Diazepam NanoparticlesAAPS PharmSciTech20151651108112125698083
   PubMed Web of Science ®Google Scholar
• HuwylerJWuDPardridgeWMBrain drug delivery of small molecules using immunoliposomesProc Natl Acad Sci U S A1996932414164141698943078
   PubMed Web of Science ®Google Scholar
• YinYChenDQiaoMLuZHuHPreparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentinJ Control Release2006116333734517097180
   PubMed Web of Science ®Google Scholar
• KumarMPandeyRSPatraKCEvaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain deliveryInt J Biol Macromol2013611018919523831532
   PubMedGoogle Scholar
• PiresAFortunaAAlvesGFalcãoAIntranasal drug delivery: how, why and what for?J Pharm Pharm Sci200912328831120067706
   PubMed Web of Science ®Google Scholar
• BhattacharjeeSErshovDvan der GuchtJSurface charge-specific cytotoxicity and cellular uptake of tri-block copolymer nanoparticlesNanotoxicology201371718422087472
   PubMed Web of Science ®Google Scholar
• DrinGCottinSBlancEReesARTemsamaniJStudies on the internalization mechanism of cationic cell-penetrating peptidesJ Biol Chem200327833311923120112783857
   PubMed Web of Science ®Google Scholar
• CritchleyHDavisSSFarrajNFIllumLNasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery systemJ Pharm Pharmacol1994466516567815278
   PubMed Web of Science ®Google Scholar
• SuzukiYALopezVLönnerdalBMammalian lactoferrin receptors: structure and functionCell Mol Life Sci200562222560257516261254
   PubMed Web of Science ®Google Scholar
• MuntimaduguEDhommatiRJainAChallaVGShaheenMKhanWIntranasal delivery of nanoparticle encapsulated tarenflurbil: a potential brain targeting strategy for Alzheimer’s diseaseEur J Pharm Sci20169222423427185298
   PubMed Web of Science ®Google Scholar
• BannermanDMRawlinsJNMchughSBRegional dissociations within the hippocampus – memory and anxietyNeurosci Biobehav Rev200428327328315225971
   PubMed Web of Science ®Google Scholar